Neurocrine Biosciences Inc
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 27,915 | 0.0% | 196,821 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 27,256 | 0.0% | 194,157 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 21,791 | 0.0% | 173,369 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 18,455 | 0.0% | 166,865 | 3/31/2025 |
| 2024 Q4 | 4/23/2025 | 61,847 | 0.0% | 453,091 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 53,249 | 0.0% | 462,147 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 66,773 | 0.0% | 485,020 | 6/30/2024 |
| 2024 Q1 | 4/30/2024 | 80,079 | 0.1% | 580,617 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 77,337 | 0.1% | 586,950 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 66,598 | 0.1% | 591,985 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 55,376 | 0.0% | 587,230 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 61,109 | 0.1% | 603,726 | 3/31/2023 |
| 2022 Q4 | 2/8/2023 | 75,430 | 0.1% | 631,534 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 69,014 | 0.1% | 649,784 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 62,924 | 0.1% | 645,504 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 61,460 | 0.0% | 655,575 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 53,562 | 0.0% | 628,882 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 20,131 | 0.0% | 209,892 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 20,537 | 0.0% | 211,026 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 21,682 | 0.0% | 222,952 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 21,671 | 0.0% | 226,088 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 20,310 | 0.0% | 211,206 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 25,133 | 0.0% | 206,006 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 17,739 | 0.0% | 204,954 | 3/31/2020 |
| 2019 Q4 | 1/27/2020 | 20,576 | 0.0% | 191,425 | 12/31/2019 |
| 2014 Q1 | 4/18/2014 | 1,455 | 0.0% | 103,500 | 3/31/2014 |
| 2013 Q4 | 2/13/2014 | 928 | 0.0% | 98,600 | 12/31/2013 |